RB
Robert Bruce (Bruce & Co) disclosed reduced in AT & T
Robert Bruce (Bruce & Co) filed a 13F change in AT & T (00206R102) on 2025-11-13, covering period end 2025-09-30.
Action
Reduced
Capital
$14,769,520 current disclosed value
Institutional 13F Signals1 evidence source
Why it matters
This signal is selected by portfolio impact within the manager filing, while the full filing change list remains available in the briefing.
Full Filing Changes
41 changes from Robert Bruce (Bruce & Co), filed 2025-11-13 for period end 2025-09-30.
$322.9M portfolio value
| Stock | Action | Change | Current | Portfolio Impact |
|---|---|---|---|---|
00287Y109 Abbvie | Increased | $5.9M | $29.5M | 1.81% |
00206R102 AT & T | Reduced | -$4.7M | $14.8M | 1.46% |
50015M109 Kodiak Sciences | Increased | $3.4M | $4.6M | 1.04% |
651639106 Newmont | Increased | $2.6M | $8.4M | 0.81% |
98389B100 XCEL Energy | Increased | $2.4M | $15.7M | 0.76% |
125896100 CMS Energy | Reduced | -$2.2M | $11.4M | 0.67% |
37833100 Apple | Increased | $1.9M | $9.9M | 0.60% |
302571104 Nextera Energy | Increased | $1.9M | $23.8M | 0.59% |
20002101 Allstate | Increased | $1.7M | $26.9M | 0.52% |
23586506 Uhaul B | Reduced | -$1.6M | $23.0M | 0.49% |
26441C204 Duke Energy | Reduced | -$1.5M | $19.3M | 0.45% |
868459108 Supernus | Increased | $1.3M | $3.9M | 0.41% |
163851108 Chemours | Increased | $1.1M | $4.0M | 0.34% |
237266101 Darling Ingredients | Reduced | -$926,170 | $4.0M | 0.29% |
589331107 Merck | Increased | $919,656 | $16.2M | 0.28% |
N00985106 AerCap Holdings | Increased | $734,000 | $22.2M | 0.23% |
39483102 Archer Daniels | Increased | $696,000 | $6.0M | 0.22% |
N51517105 Lava Theraputics | Sold out | -$688,874 | $0 | 0.21% |
00430HAC6 Accelerate Diagnostic | Sold out | -$658,515 | $0 | 0.20% |
N53745100 Lyondellbasell | Increased | $628,000 | $2.9M | 0.19% |
31189P102 Fate Theraputics | Increased | $438,086 | $918,777 | 0.14% |
925815102 Vicor | Increased | $392,400 | $4.5M | 0.12% |
45774W108 Insteel | Increased | $388,068 | $13.2M | 0.12% |
717081103 Pfizer | Increased | $337,156 | $6.9M | 0.10% |
56400P706 Mannkind | Increased | $317,969 | $1.0M | 0.10% |
749607107 RLI | Reduced | -$285,600 | $2.7M | 0.09% |
2824100 Abbott | Reduced | -$276,966 | $17.9M | 0.09% |
142038108 Caribou Biosciences | Increased | $267,500 | $582,500 | 0.08% |
23586100 Uhaul | Reduced | -$257,911 | $4.2M | 0.08% |
92333F101 Venture Global | Reduced | -$139,000 | $1.4M | 0.04% |
65443P102 908 Devices | Increased | $111,306 | $598,185 | 0.03% |
268311107 EDAP | Increased | $105,297 | $1.0M | 0.03% |
H11356104 Bunge | Increased | $77,600 | $6.5M | 0.02% |
92556V106 Viatris | Increased | $56,531 | $576,962 | 0.02% |
92939U106 WEC Energy | Increased | $40,989 | $452,058 | 0.01% |
91911K102 Bausch Health | Reduced | -$35,910 | $1.1M | 0.01% |
44209104 Ashland | Reduced | -$35,550 | $718,650 | 0.01% |
532457108 Eli Lilly | Reduced | -$33,060 | $1.5M | 0.01% |
05379B107 Avista | Reduced | -$28,210 | $7.6M | 0.01% |
82968B103 XM Sirius | Increased | $17,015 | $1.3M | 0.01% |
71535D106 Personalis | Reduced | -$10,120 | $1.6M | 0.00% |